An Interactive Annotated World Bibliography of Printed and Digital Works in the History of Medicine and the Life Sciences from Circa 2000 BCE to 2022 by Fielding H. Garrison (1870-1935), Leslie T. Morton (1907-2004), and Jeremy M. Norman (1945- ) Traditionally Known as “Garrison-Morton”

15961 entries, 13944 authors and 1935 subjects. Updated: March 22, 2024

WYSS, Rolf

1 entries
  • 12469

Effet d’un stéroide anti-progestérone chez la femme: Interruption du cycle menstruel et de la grossesse au début.

Compt. Rend. l'Acad. Sci., Sér. III, 294, 933–8, 1982.

"In April 1980, as part of a formal research project at the French pharmaceutical company Roussel-Uclaf for the development of glucocorticoid receptor antagonists, chemist Georges Teutsch synthesized mifepristone (RU-38486, the 38,486th compound synthesized by Roussel-Uclaf from 1949 to 1980; shortened to RU-486), which was discovered to also be a progesterone receptor antagonist.[54][55] In October 1981, endocrinologist Étienne-Émile Baulieu, a consultant to Roussel-Uclaf, arranged tests of its use for medical abortion in 11 women in Switzerland by gynecologist Walter Herrmann at the University of Geneva's Cantonal Hospital, with successful results announced on April 19, 1982" (Wikipedia article on Mifepristone, accessed 4-2020).



Subjects: OBSTETRICS & GYNECOLOGY › OBSTETRICS › Abortion, PHARMACOLOGY › PHARMACEUTICALS › Abortion